These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10500437)

  • 1. [Prediction of therapeutic response in breast carcinoma: predictive factors].
    Nesković-Konstantinović Z
    Srp Arh Celok Lek; 1999; 127(3-4):131-6. PubMed ID: 10500437
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical-biological meaning of progesterone receptor status in 118 estrogen receptor positive infiltrating ductal carcinomas of the breast in post-menopausal women].
    Ruibal A; Schneider J; Arias J; del Río MC; Núnez MJ; Tejerina A
    Rev Esp Med Nucl; 2000 Jun; 19(3):244-6. PubMed ID: 11062090
    [No Abstract]   [Full Text] [Related]  

  • 3. Triple negative, basal cell type and EGFR positive invasive breast carcinoma in Kuwaiti and British patients.
    Ayad E; Francis I; Peston D; Shousha S
    Breast J; 2009; 15(1):109-11. PubMed ID: 19077133
    [No Abstract]   [Full Text] [Related]  

  • 4. [An aggressive subtype of breast carcinoma].
    Dauplat MM; Mishellany F; Delatour M; Penault-Llorca F
    Ann Pathol; 2003 Dec; 23(6):611-2. PubMed ID: 15094600
    [No Abstract]   [Full Text] [Related]  

  • 5. Time for reappraisal of progesterone-receptor testing in breast cancer management.
    MacGrogan G; de Mascarel I; Sierankowski G; Mauriac L; Debled M; Durand M; De Lara CT; Avril A; Picot V; Mathoulin-Pélissier S
    J Clin Oncol; 2005 Apr; 23(12):2870-1; author reply 2871. PubMed ID: 15838009
    [No Abstract]   [Full Text] [Related]  

  • 6. Nonlinear discriminant analysis and prognostic factor classification in node-negative primary breast cancer using probabilistic neural networks.
    Le Goff JM; Lavayssière L; Rouëssé J; Spyratos F
    Anticancer Res; 2000; 20(3B):2213-8. PubMed ID: 10928180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination and significance of hormone receptors in breast carcinoma].
    Marugo M; Bernasconi D; Sorice G; Fazzuoli L
    Ann Ital Chir; 1991; 62(5):461-5. PubMed ID: 1801624
    [No Abstract]   [Full Text] [Related]  

  • 8. Receptors for epidermal growth factor and sex steroid hormones in human colorectal carcinomas.
    Magnusson I; Rosen AV; Nilsson R; Macias A; Perez R; Skoog L
    Anticancer Res; 1989; 9(2):299-301. PubMed ID: 2751256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and predictive factors in breast cancer.
    Bundred NJ
    Cancer Treat Rev; 2001 Jun; 27(3):137-42. PubMed ID: 11417963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
    Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Overgaard J;
    J Clin Oncol; 2008 Mar; 26(9):1419-26. PubMed ID: 18285604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new look at the prognostic value of the estrogen, progesterone and epidermal growth factor receptors in breast cancer tissue.
    Skasko E; Paszko Z; Mazur S
    Neoplasma; 2005; 52(1):10-7. PubMed ID: 15739020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for initial lung metastasis from breast invasive ductal carcinoma in stages I-III of operable patients.
    Gao D; Du J; Cong L; Liu Q
    Jpn J Clin Oncol; 2009 Feb; 39(2):97-104. PubMed ID: 19052036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biological features of breast cancer in patients under 35].
    Damenia AO; Turkevich EA; Semiglazov VF; Kochetova IA; Gurbanov SS; Bit-Sava EM; Efimenko AV
    Vopr Onkol; 2007; 53(6):674-6. PubMed ID: 18416136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen and progesterone receptor isoforms: clinical significance in breast cancer.
    Fuqua SA; Cui Y
    Breast Cancer Res Treat; 2004; 87 Suppl 1():S3-10. PubMed ID: 15597215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliance on hormone receptor assays of surgical specimens may compromise outcome in patients with breast cancer.
    Mann GB; Fahey VD; Feleppa F; Buchanan MR
    J Clin Oncol; 2005 Aug; 23(22):5148-54. PubMed ID: 16051956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of epidermal growth factor receptor in breast cancer, from early stages to advanced disease.
    Nesković-Konstantinović Z; Nikolić-Vukosavljević D; Branković-Magić M; Kanjer K; Gavrilović D; Mitrović L; Borojević N; Vukotić D; Spuzić I
    J Exp Clin Cancer Res; 1999 Sep; 18(3):347-55. PubMed ID: 10606181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
    Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM
    J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple negative breast cancer: clinicopathological characteristics and treatment strategies.
    Akiyama F; Iwase H
    Breast Cancer; 2009; 16(4):252-3. PubMed ID: 19506994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunohistochemical investigation of estrogen and progesterone receptors in breast tumors].
    Ellinidi VN; Anikseeva NV; Goncharova OA; Krasnozhon DA; Fedorov KA
    Vopr Onkol; 2004; 50(2):234-6. PubMed ID: 15176229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of steroid hormone receptor determination in breast carcinoma tissue].
    Holtkamp W
    Dtsch Med Wochenschr; 1990 Sep; 115(38):1442-7. PubMed ID: 2209424
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.